期刊文献+

三种促排卵方案在卵巢低反应患者行体外受精-胚胎移植中的临床研究

下载PDF
导出
摘要 随着辅助生殖技术的进步,体外受精-胚胎移植的成功率逐年在提高,但是对于卵巢低反应的患者成功率总不尽人意,目前也是从事辅助生殖工作者面临的棘手问题。其原因可能是随着社会的发展,患者压力增大、环境污染、生育年龄推迟,致使卵巢低反应的不孕症患者越来越多,文献[1]报道其发生率为9%~24%,这部分患者促性腺激素(Gn)使用量明显增加,周期取消率高,获卵数少,妊娠率低,早期流产率高[2]。如何提高这部分患者的成功率,选择合适的促排卵方案,已成为生殖医学研究的热点之一。本研究回顾性地分析了从2011年1月至2013年12月在本院生殖中心接受体外受精/卵胞质内单精子注射-胚胎移植(IVF/ICSI-ET)治疗的卵巢低反应患者共120例159个周期,采用3种不同的促排卵方式进行治疗,分析其临床结局,现报告如下。
出处 《中国药物与临床》 CAS 2014年第11期1539-1541,共3页 Chinese Remedies & Clinics
基金 山西省科技攻关项目(20120313025-9)
  • 相关文献

参考文献9

  • 1曹云莉,孙海翔,王俊霞,徐志鹏,王玢.卵巢低反应周期的受精方式对助孕结局的影响[J].江苏医药,2012,38(12):1436-1438. 被引量:7
  • 2Ulug U, Ben-Shlomo I,Turan E ,et al. Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles [J]. Reprod Biomed Online, 2003,6(4) : 439-443.
  • 3Ubaldi FM,Rienzi L,Ferrero S,et al. Management of poor re- sponders in IVF [J]. Rcprod Biomed Online,2005,10 (3) :235- 246.
  • 4Gareia JE,Jones GS,Acosta AA,et al. Human menopausal go- nadotropin/human chorionic gonadotropin follicular maturation for ooeyte aspiration: phase Ⅱ , 1981 [J]. Fertil Stefil, 1983,39(2) : 174-179.
  • 5朱小明,蔡婕,黄荷凤.卵巢低反应的诊断标准和预测[J].中国实用妇科与产科杂志,2006,22(5):388-390. 被引量:50
  • 6Baart EB,Martin E,Eijkemans MJ,et al. Milder ovarian stimula- tion fir in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial[J]. Hum Reprod, 2007,22: 980-988.
  • 7Ma WG,Song H,Das SK,et al. Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation[J]. Proe Natl Acad Sci USA.2003.100: 2963-2968.
  • 8刘嘉茵.微刺激方案治疗卵巢低反应IVF周期[J].实用妇产科杂志,2007,23(3):134-135. 被引量:20
  • 9Mitwally MF,Casper RF. Aromatase inhibition reduces go- nadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility [J]. Hum Reprod,2003,18: 1588-1597.

二级参考文献23

  • 1Ubaldi FM,Rienzi L,Ferrero S,et al.Management of poor responders in IVF[J].Reprod Biomed Online,2005,10(3):235-246.
  • 2Sallam HN,Ezzeldin F,Agameya AF,et al.Defining poor responders in assisted reproduction[J].Int J Fertil Womens Med,2005,50(1):115-120.
  • 3van Rooij IA,Bancsi LF,Broekmans FJ,et al.Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization[J].Fertil Steril,2003,79 (5):482 -488.
  • 4Abdalla H,Thum MY.An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve[J].Hum Reprod,2004,19(5):893-898.
  • 5Bancsi LF,Broekmans FJ,Mol BW,et al.Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization:a meta-analysis[J].Fertil Steril,2003,79 (6):1091-1100.
  • 6Barroso G,Oehninger S,Monzo A,et al.High FSH:LH ratio and low LH levels in basal cycle day 3:impact on follicular development and IVF outcome[J].J Assist Reprod Genet,2001,18(5):499-505.
  • 7Ho JY,Guu HF,Yi YC,et al.The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders"[J].Fertil Steril,2005,83(9):883-888.
  • 8Themmen AP.Anti-Mullerian hormone:its role in follicular growth initiation and survival and as an ovarian reserve marker[J].J Natl Cancer Inst Monogr,2005,20 (1):18-21.
  • 9Muttukrishna S,Suharjono H,McGarrigle H,et al.Inhibin B and anti-Mullerian hormone:markers of ovarian response in IVF/ICSI patients?[J].B J Obstet Gynecol,2004,111 (7):1248-1253.
  • 10Muttukrishna S,McGarrigle H,Wakim R,et al.Antral follicle count,anti-mullerian hormone and inhibin B:predictors of ovarian response in assisted reproductive technology?[J].B J Obstet Gynecol,2005,112 (7):1384-1390.

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部